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Background. It is unclear if clinicians evaluate for concurrent bacteremia or UTI in young patients diagnosed with acute otitis
media (AOM). Objectives. To describe how often, and under which circumstances, emergency providers investigate for bacteremia
or UTI in 2–36 month olds with AOM. Methods. Cases of AOM were analyzed from the 2001–2004 National Hospital Ambulatory
Medical Care Survey (NHAMCS)-Emergency Department dataset. Results. AOM was diagnosed in 17% of the 10,847 recorded
visits of 2–36 month olds. Of these visits, laboratory testing included: CBC: 7%, Blood culture: 4%, urinalysis or urine culture:
5%, and any of these tests: 9%. Rates of testing for 2–6 month olds with temperature ≥ 38.0 (CBC: 13%, blood culture: 9%,
urinalysis or urine culture: 7%, any of the tests: 14%) were not significantly diﬀerent from testing of patients aged 6–12 months,
or 12–36 months (all P > .1). Patients with temperature of ≥ 39.0 were more likely to have all tests, with the exception of urine
investigation, than patients with temperature between 38.0 and 38.9. Conclusions. 17% of 2–36 month old patients seen in the
emergency department are diagnosed with AOM. Investigating for bacteremia or UTI in these patients is not routine, even in
febrile infants.

1. Introduction
Acute otitis media (AOM) is the most common infection for
which antibiotics are prescribed for children in the United
States [1]. There were 2.6 million emergency department
visits for AOM in 1996, and 2.1 million visits in 2005
[2]. AOM is often associated with fussiness, otalgia, and
fever, but these signs and symptoms are nonspecific and
are associated with other childhood infections [1]. Although
young children with fever commonly have AOM or a viral
illness, some febrile children have occult bacterial infections,
such as bacteremia or urinary tract infection (UTI).
Streptococcus pneumoniae is a known cause of AOM
and bacteremia in children. Data published prior to the
introduction of the pneumococcal conjugate vaccine (PCV)
in February 2000 showed that rates of bacteremia in febrile
3–36-month-olds diagnosed with AOM were similar to those

without a source of fever [3]. Another study showed that
febrile 3–36-month-olds with a bacterial source of infection
(including AOM) had similar rates of bacteremia as those
without a focal bacterial source of their fever [4].
The PCV has been associated with a moderate decrease
in the overall incidence of AOM [5–8]. Many studies have
also documented a decrease in streptococcus pneumoniae
bacteremia since the introduction of the PCV in February,
2000 [9–14]. One study involved the evaluation of 2–
36-month-olds with fever ≥ 39.0 who presented to either
emergency departments or urgent care centers, excluding
patients who had a focal bacterial source of infection, other
than AOM. The rate of bacteremia in this population was
0.9% [15]. Another study showed that 0.9% of all febrile
patients’ ages 57–180 days presenting to the emergency
department were bacteremic. This same study reported that
the incidence of urinary tract infection (UTI) was 9.7% [16].
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In another study which included children up to two years of
age, 5.9% were found to have UTI in those without a source
of fever, and 2.7% of those with AOM or other source of fever
had a UTI [17]. These studies suggest that in those with AOM
the incidence of UTI is low, and the incidence of bacteremia
is rare.
The main objective of this study is to characterize the
extent that emergency practitioners investigate for bacteremia or UTI in 2–36-month-old patients diagnosed with
AOM in the four years following the introduction of the
PCV. A second goal is to identify if temperature or age are
associated with higher rates of testing. Whether a complete
blood count (CBC) is performed as part of the laboratory
investigation will also be described as this test has been used
to predict bacteremia [18, 19].

2. Methods
2.1. Study Design. We analyzed data from The National
Hospital Ambulatory Medical Care Survey (NHAMCS)Emergency Department from 2001–2004 [20]. The study
was ruled exempt from informed consent by the local
institutional review committee.
2.2. Study Setting and Population. The National Hospital
Ambulatory Medical Care Survey (NHAMCS) is designed
to collect data on the utilization and provision of ambulatory care services in hospital emergency and outpatient
departments in the United States. The NHAMCS dataset is
a nationally representative multistage stratified probability
sample of visits to the emergency departments and outpatient departments of noninstitutional general and shortstay hospitals within the United States, excluding federal,
military, and Veterans Administration hospitals. The study
is administered by the Division of Health Care Statistics,
Centers for Disease Control and Prevention. Only data
regarding emergency visits were included in this study.
2.3. Study Protocol. Interviewers visit the hospitals prior
to their participation in the survey to explain survey
procedures, verify eligibility, develop a sampling plan, and
train hospital staﬀ in data collection procedures. The survey
instrument is the patient record form. Hospital staﬀ is
instructed to complete patient record forms for a random
sample of patient visits during a randomly assigned 4-week
reporting period. The U.S. Bureau of the Census acts as the
field data collection agent for the NHAMCS.
2.4. Measurements. A case of AOM was identified if the
International Classification of Diseases, Ninth Revision
(ICD-9) code of 382.9 was noted in the primary or
secondary diagnosis. If AOM was identified as a secondary
diagnosis, the ICD-9 code for the primary diagnosis was
identified. Demographic data and primary reason for visit
were recorded for each case of AOM. Boxes on the data
form were checked if a complete blood count (CBC), blood
culture, urine culture, and urinalysis were performed at
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the visit. Whether an electrocardiogram (ECG), electroencephalogram (EEG), magnetic resonance image (MRI), or
Computerized Axial Tomography scan (CT) was obtained
was recorded in a similar fashion. Final disposition of the
patient was also identified for each case. For purposes of
analysis, the term “urine investigation” was used to define
a patient that had either a urinalysis or a urine culture
performed. The term “any testing” was used to describe a
patient who had at least one of the following; CBC, blood
culture, or urine investigation.
2.5. Data Analysis. We utilized four years of data (2001–
2004). These four years were chosen for study as each
of the essential data fields (acute otitis media diagnosis,
temperature, CBC, blood culture, urinalysis, urine culture)
were obtained similarly with no alteration in the yearly
survey instrument. Alterations in the methodology of data
collected after 2004 from the previous year’s methodology
prevented inclusion of years beyond 2004.
Patients were included if their primary or secondary
diagnosis was AOM. Patients were excluded from the study
if temperature was not recorded or if investigation for an
alternative diagnosis was undertaken (ECG, EEG, MRI/CT).
Patients were also excluded if the disposition was admission
to a hospital or transfer to another facility. Each of these
circumstances was thought to represent a population of
children that had a more complex clinical presentation.
Therefore, after exclusions, the expectation was that the
sample would be comprised of children with uncomplicated
AOM that was managed as an outpatient.
Bivariate associations using chi-square analyses were
performed to assess laboratory testing performed by temperature stratified by age (2–6 months versus 6–12 months
versus 12–36 months). The proportion of subjects who
received each laboratory test was compared between each of
the four years of data to identify trends in laboratory investigation over the duration of the study. Multivariable logistic
regression analyses were performed on febrile patients to
predict laboratory testing based on temperature, age, gender,
insurance type (private, Medicaid/SCHIP, Self-pay, or other),
and race/ethnicity (white, black, Hispanic, or other). Stata
version 10.1 (Stata Corp, College Station, Texas) was used to
adjust for the complex sampling design.

3. Results
Data were collected from 10,847 emergency department
visits of 2–36-month-old patients from 2001–2004. 17% of
these patients received a primary (13%) or secondary (4%)
diagnosis of AOM. Further analyses were performed on
these 17% diagnosed with AOM. Of these patients, 3% were
excluded because temperature was not recorded. Another
0.9% was excluded because they were either admitted to the
hospital or transferred to another hospital. Less than 0.01%
was excluded for having an ECG, EEG, or MRI/CT. After
exclusions, 96% of all 2–36-month-old patients diagnosed
with AOM remained in the study sample for further analyses
(n = 1881). Characteristics of the study sample are shown
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in Table 1. Of note, 57% of the children who had a diagnosis
of AOM had a triage temperature less than 38.0◦ C. Of those
included in the study with a secondary diagnosis of AOM,
the primary diagnosis is listed in Table 2.
Overall, 7% had a CBC, 3% had a blood culture, 4% had
a urinary investigation, and 9% had any of these laboratory
tests. Overall trends of obtaining laboratory testing (CBC,
blood culture, urine investigation, or any testing) did not
vary significantly from year to year during the four years of
data collection (all P > .1 for each test). Likewise, laboratory
testing rates for each test were not statistically diﬀerent
between those with a primary diagnosis of AOM compared
to those with a secondary diagnosis of AOM after adjusting
for fever and multiple comparisons (all P ≥ .1). Rates of
each laboratory test stratified by age group and temperature
are shown in Table 3. Overall rates of obtaining individual
tests, or any testing, in patients with temperature <38.0 were
extremely low. Rates of testing were not significantly diﬀerent
between the three age groups in patients with temperature
≥ 38.0. Rates of testing were also evaluated for infants with
temperature ≥ 39.0. Due to a low sample size of 2–6-montholds with temperature ≥39.0, 2–6-month and 6–12-montholds were combined for analyses. In 2–12-month-olds with
temperature ≥ 39.0 rates of testing included: CBC 19%,
blood culture 10%, urine investigation 12%, and any testing
24%.
Multivariable analyses were performed on only those
patients with a diagnosis of AOM and a temperature of
≥ 38.0 (Table 4). Patients with temperature of ≥ 39.0 were
more likely to have all tests, with the exception of urine
investigation, than patients with temperature between 38.0
and 38.9. In addition, there were no statistically diﬀerent
rates of testing between young infants (2–6 months) and
older infants (6–12 months), or toddlers (12–36 months).
Gender, insurance type, and race/ethnicity were included in
the model, but were not found to be significantly associated
with laboratory testing.
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Table 1: Description of patients diagnosed with acute otitis media.
Gender
Male
Female
Age
2–6 months
6–12 months
12–35 months
Race/Ethnicity
White (non-Hispanic)
Hispanic
Black (non-Hispanic)
Other
Temperature at Triage
Less than 38.0
38.0–38.9
Above 39.0
Insurance
Private Insurance
Medicaid/SCHIP
Self-pay
Other
Chief Complaint
Fever
Respiratory∗
Ear complaint#
Gastrointestinal+
Rash
Cranky/Fussy
Other

55%
45%
10%
28%
62%
49%
24%
23%
4%
57%
21%
22%
32%
53%
7%
7%
38%
18%
16%
7%
4%
2%
15%

∗ Includes

upper respiratory infection, cough, or nasal congestion.
ear pain, pulling ear, ear discharge, ear infection.
+ Includes vomiting, nausea, and diarrhea.
# Includes

4. Discussion

Table 2: Primary diagnosis of those with a secondary diagnosis of
acute otitis media.

The diagnosis of AOM is common: 17% of all 2–36-montholds presenting to emergency departments in the United
States are diagnosed with AOM. Nearly all of these patients
are discharged home. A previous publication from this
dataset noted that antibiotics are prescribed to a majority of
these children [2]. This study aimed to describe the extent
that clinicians evaluate for bacteremia or UTI in patients
diagnosed with AOM in the emergency department.
This study helps to clarify that evaluating for bacteremia or UTI is not routinely pursued in 2–36-montholds diagnosed with AOM in the emergency department.
It is of note, however, that approximately one quarter of
all 2–12-month-olds with fever ≥39.0 had a CBC, blood
culture or urine investigation performed. Investigating for
bacteremia was nearly as common as investigating for a
urinary source of infection. Previous data suggest that
rates of urinary infections are much higher than rates of
bacteremia, but our results do not suggest higher vigilance in

Diagnosis
(1) Viral∗
(2) General symptoms or fever
(3) Bronchitis/bronchiolitis
(4) Asthma
(5) Gastroenteritis/digestive symptoms
(6) Pharyngitis/tonsillitis/laryngitis
(7) Rash/Skin condition
(8) Pneumonia
(9) Conjunctivitis
(10) Ear pain/otitis externa
(11) Febrile seizure
(12) Sinusitis
(13) Other
∗ Viral

%
31
25
9
6
6
5
4
3
2
2
2
1
5

includes diagnoses of influenza, common cold, viral illness, upper
respiratory infection, respiratory illness, and croup.
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Table 3: Laboratory evaluation of 2–36-month-old patients with acute otitis media stratified by temperature and age in months.
<38.0
6–12

Test

2–6

CBC
Blood Culture

5%
3%

3%
1%

Urine Investigation
Any of the Above

3%
5%

2%
4%

∗ All

P-Value

2–6

≥38.0
6–12

12–36

3%
1%

.41
.02

13%
9%

15%
8%

13%
6%

.75
.64

1%
3%

.09
.51

7%
14%

11%
20%

6%
20%

.12
.34

12–36

∗

∗

P-Value

P-Values denote diﬀerences between three age categories.

Table 4: Adjusted odds ratios (OR) from multivariable logistic regression for obtaining laboratory tests in patients with acute otitis media
and temperature ≥38.0.
CBC
OR (95% CI)
Age
2–6 months
6–12 months
12–36 months
Temperature ◦ C
38.0–38.9
≥39.0

P-value

1.0 [reference]

Blood culture
OR (95% CI)
P-value

Urine investigation
OR (95% CI)
P-value

Any testing
OR (95% CI)
P-value

1.0 [reference]

1.0 [reference]

1.0 [reference]

1.0 (0.4–2.4)
0.8 (0.3–2.0)

.98
.66

0.8 (0.2–2.6)
0.6 (0.2–2.0)

.72
.42

1.5 (0.5–4.9)
0.8 (0.2–2.6)

.45
.72

1.3 (0.6–3.0)
1.0 (0.4–2.3)

.51
.96

1.0 [reference]
2.0 (1.2–3.4)

.01

1.0 [reference]
2.4 (1.2–4.7)

.01

1.0 [reference]
1.5 (0.8–3.0)

.22

1.0 [reference]
1.7 (1.0–2.9)

.05

investigating a urinary source of infection over bacteremia.
It is possible that there is a perception that although UTI
is more common, bacteremia is more serious, and therefore
should be investigated more thoroughly. There also exists the
possibility that a urinary catheter is viewed as a more invasive
procedure than a venipuncture, and therefore clinicians are
less likely to catheterize a young patient.
It is unclear if other factors lead certain clinicians to
pursue laboratory testing in young patients with AOM. It
is conceivable that some clinicians may have uncertainty
distinguishing between otitis media with eﬀusion (OME)
and AOM. Previous literature has shown that clinicians
often misdiagnose OME as AOM [21, 22]. Perhaps clinicians
who diagnose AOM, but do so with uncertainty, are more
likely to aggressively evaluate the patient as they view this
patient as one without a source of infection. Further research
could investigate if clinicians base their decision to perform
laboratory testing on their confidence level of their diagnosis
of AOM. Another possibility is that despite a confident
diagnosis of AOM, a clinician may still feel the risk of
bacteremia or UTI is suﬃcient to warrant testing. This
management would be supported by previous literature
suggesting that a focal infection decreases, but does not
eliminate, the possibility of bacteremia or UTI [16].
The primary strength of this study is that it is based
on a national sample of infants and children presenting to
emergency departments. This reflects care of children both
within and outside of children’s hospitals. This study is
relevant to all clinicians who treat children as AOM is the
most common infection for which antibiotics are prescribed
in childhood.

5. Limitations
There are limitations to this study. The most important
of these is that there is no knowledge of the results of
the laboratory testing that was performed. Therefore, this
paper does not address whether clinicians should evaluate
for bacteremia or UTI in patients diagnosed with AOM.
These data only provide evidence that testing is not routine,
even in febrile younger patients. Also, it would have been
helpful to describe the percentage of young infants (2–
6 months of age) with temperature ≥39.0 who receive a
laboratory evaluation. Our data demonstrate that AOM is
not as common in 2–6-month-olds as it is in older infants.
Therefore, there was an inadequate sample of 2–6-month
olds with temperature ≥39.0 to make accurate comparisons
to those with a temperature of 38.0-39.0, or to those between
6–12 months of age. The multivariable analyses do suggest
that 2–6-month-olds do not receive more testing than 6–12month-olds, but further study would be needed to accurately
describe testing rates of 2–6-month-olds with fever ≥39.0.
Also, when a urinalysis was ordered by a clinician, the
intention of the urinalysis could not be determined from
these data. For example, a urinalysis may be performed to
assess for dehydration or to investigate for an infection. There
is no mechanism to know from these data why the test was
ordered. We assumed that anytime a urinalysis or a urine
culture was performed, the clinician was investigating for
infection. Therefore, we may be overestimating the number
of clinicians who were investigating for a UTI.
Lastly, whether or not a provider was aware of the PCV
vaccine status of the participants in the study is not noted in
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these data. This would have helped clarify if clinical decisions
were based on the vaccination status of the participant.
Much of the medical literature documenting the clinical
decrease in rates of streptococcus pnuemoniae bacteremia
due to the PCV was not available in 2001–2004. Therefore,
even if providers were aware that a participant received the
PCV, it is possible that providers may have based clinical
management upon their knowledge of the higher rates of
streptococcus pnuemoniae bacteremia that existed prior to the
PCV licensure in 2000. As such, providers in this study may
have been more likely to evaluate for bacteremia than those
in the years following the study.

6. Conclusion
From 2001–2004, 17% of 2–36-month-olds who presented to
emergency departments in the United States were diagnosed
with AOM. Evaluating for bacteremia or UTI was not
routinely performed. Less than one in four infants with AOM
and fever ≥ 39.0 was investigated for these occult infections.
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